Shumin Li

机构：Nanyang Technological University · ORCID：0000-0001-8083-1071

发表论文 122 篇 · 总被引 1721 次 · h-index 25

代表论文

• Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib (2024 · Molecular Cancer · 被引 40)
• Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice (2025 · Nature Communications · 被引 39)
• CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment (2025 · Journal for ImmunoTherapy of Cancer · 被引 17)
• Iron consumption strengthens anti-tumoral STING activation mediated by manganese-based nanoparticles (2024 · Nano Today · 被引 14)
• Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma (2024 · Cancer Cell International · 被引 13)
• Sepsis and the diverse organ-gastrointestinal tract axis (2025 · World Journal of Critical Care Medicine · 被引 10)